{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:57:58Z","timestamp":1786636678948,"version":"build-2736575974"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Gastroenterol"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/1319-3767.93807","type":"journal-article","created":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T05:49:34Z","timestamp":1331704174000},"page":"87","source":"Crossref","is-referenced-by-count":27,"title":["Therapeutic applications of octreotide in pediatric patients"],"prefix":"10.4103","volume":"18","author":[{"given":"Abdulrahman","family":"Al-Hussaini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decker","family":"Butzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-3767.93807-1","first-page":"14","volume-title":"Pharmacodynamic effects of Sandostatin in the gastrointestinal tract","author":"Gyr","year":"1993","journal-title":"Digestion"},{"key":"key-10.4103\/1319-3767.93807-2","first-page":"5S","volume-title":"Biochemistry and physiology of gastrointestinal somatostatin","author":"Lucey","year":"1989","journal-title":"Dig Dis Sci"},{"key":"key-10.4103\/1319-3767.93807-3","first-page":"141","volume-title":"Inhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogue","author":"Whitehouse","year":"1986","journal-title":"Gut"},{"key":"key-10.4103\/1319-3767.93807-4","first-page":"11","volume-title":"Somatostatin localisation in tissues","author":"Polak","year":"1986","journal-title":"Scand J Gastroenterol Suppl"},{"key":"key-10.4103\/1319-3767.93807-5","first-page":"738","volume-title":"Effect of long acting somatostatin-analogue, SMS 201-995, on gut hormone secretion in normal subjects","author":"Kraenzlin","year":"1985","journal-title":"Experientia"},{"key":"key-10.4103\/1319-3767.93807-6","first-page":"108","volume-title":"Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men","author":"Lembcke","year":"1987","journal-title":"Digestion"},{"key":"key-10.4103\/1319-3767.93807-7","first-page":"304","volume-title":"Clinical use of the long acting somatostatin analogue octreotide in pediatrics","author":"Tauber","year":"1994","journal-title":"Eur J Pediatr"},{"key":"key-10.4103\/1319-3767.93807-8","first-page":"600","volume-title":"Octreotide in pediatric patients","author":"Heikenen","year":"2002","journal-title":"J Pediatr Gasroenterol Nutr"},{"key":"key-10.4103\/1319-3767.93807-9","first-page":"41","volume-title":"Octreotide therapy for control of acute gastrointestinal bleeding in children","author":"Eroglu","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key-10.4103\/1319-3767.93807-10","first-page":"1061","volume-title":"Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide","author":"Grosman","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/1319-3767.93807-11","first-page":"1184","volume-title":"Emerging indications for octreotide therapy, Part 1","author":"Mosdell","year":"1994","journal-title":"Am J Hosp Pharm"},{"key":"key-10.4103\/1319-3767.93807-12","doi-asserted-by":"crossref","unstructured":"Hadengue A. Somatostatin or octreotide in acute variceal bleeding. Digestion 1999;60 (Suppl 2):31-41","DOI":"10.1159\/000051478"},{"key":"key-10.4103\/1319-3767.93807-13","first-page":"489","volume-title":"Octreotide reduces azygous blood flow in cirrhotic patients with portal hypertension","author":"McCormick","year":"1990","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key-10.4103\/1319-3767.93807-14","first-page":"320","volume-title":"A randomized controlled trial comparing octreotide and vasopressin in the control of acute oesophageal bleeding","author":"Hwang","year":"1992","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.93807-15","first-page":"555","volume-title":"Sclerotherapy with or without octreotide for acute variceal bleeding","author":"Besson","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1319-3767.93807-16","first-page":"1666","volume-title":"Prospective randomised study of effect of octreotide in rebleeding from oesophageal varices after endoscopic ligation","author":"Sung","year":"1995","journal-title":"Lancet"},{"key":"key-10.4103\/1319-3767.93807-17","first-page":"339","volume-title":"Use of octreotide in the acute management of bleeding oesophageal varices","author":"Sadowski","year":"1997","journal-title":"Can J Gastroenterol"},{"key":"key-10.4103\/1319-3767.93807-18","first-page":"356","volume-title":"Use of octreotide for the treatment of severe gastrointestinal bleeding in children","author":"Siafakas","year":"1998","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key-10.4103\/1319-3767.93807-19","first-page":"404","volume-title":"Management of massive gastrointestinal haemorrhage from multiple sites of peptic ulceration with somatostatin and octreotide- A report of five cases","author":"Jenkins","year":"1992","journal-title":"Gut"},{"key":"key-10.4103\/1319-3767.93807-20","first-page":"246","volume-title":"Octreotide","author":"Lamberts","year":"1996","journal-title":"N Eng J Med"},{"key":"key-10.4103\/1319-3767.93807-21","first-page":"243","volume-title":"The effect of octreotide as an adjunct treatment in active nonvariceal upper gastrointestinal bleeding","author":"Nikolopoulou","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"key-10.4103\/1319-3767.93807-22","first-page":"568","volume-title":"Placebo-controlled trial with the somatostatin analogue SMS 201-995 in peptic ulcer bleeding","author":"Christiansen","year":"1989","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.93807-23","first-page":"856","volume-title":"Octreotide for arrest of peptic ulcer haemorrhage - a prospective, randomized controlled trial","author":"Lin","year":"1995","journal-title":"Hepatogastroenterology"},{"key":"key-10.4103\/1319-3767.93807-24","first-page":"206","volume-title":"Conservative management of pediatric pancreatic pseudocyst using octreotide acetate","author":"Mulligan","year":"1995","journal-title":"Am Surg"},{"key":"key-10.4103\/1319-3767.93807-25","first-page":"422","volume-title":"Somatostatin in the treatment of pancreatic pseudocyst in a child","author":"Bosman-Vermeeren","year":"1996","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key-10.4103\/1319-3767.93807-26","first-page":"445","volume-title":"Somatostatin in the treatment of pancreatic pseudocyst complicating acute pancreatitis in a child with liver transplantation","author":"Tissieres","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key-10.4103\/1319-3767.93807-27","first-page":"135","volume-title":"Resolution of pancreatic ascites with octreotide","author":"Rushforth","year":"1993","journal-title":"Arch Dis Child"},{"key":"key-10.4103\/1319-3767.93807-28","first-page":"192","volume-title":"Somatostatin and octreotide in acute pancreatitis: the never-ending story","author":"Cavallini","year":"2001","journal-title":"Dig Liver Dis"},{"key":"key-10.4103\/1319-3767.93807-29","first-page":"112","volume-title":"The effects of somatostatin and octreotide on experimental and human acute pancreatitis","author":"Greenberg","year":"2000","journal-title":"J Lab Clin Med"},{"key":"key-10.4103\/1319-3767.93807-30","first-page":"450","volume-title":"Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide","author":"Malfertheiner","year":"1995","journal-title":"Gut"},{"key":"key-10.4103\/1319-3767.93807-31","first-page":"992","volume-title":"Treatment of acute pancreatitis with somatostatin.Results of the multi-center double-blind trial (APTS-Study)","author":"Usadel","year":"1985","journal-title":"Dig Dis Sci"},{"key":"key-10.4103\/1319-3767.93807-32","first-page":"92","volume-title":"The use of somatostatin in acute pancreatitis: Results of a multi-center trial","author":"D\u2032Amico","year":"1990","journal-title":"Hepatogastroenterology"},{"key":"key-10.4103\/1319-3767.93807-33","first-page":"223","volume-title":"Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial","author":"Choi","year":"1989","journal-title":"Gut"},{"key":"key-10.4103\/1319-3767.93807-34","first-page":"1065","volume-title":"Effect of somatostatin 14 on pure human pancreatic secretion","author":"Gullo","year":"1987","journal-title":"Dig Dis Sci"},{"key":"key-10.4103\/1319-3767.93807-35","first-page":"409","volume-title":"Initial experience with octreotide in the pediatric population","author":"Lam","year":"2001","journal-title":"Am J Ther"},{"key":"key-10.4103\/1319-3767.93807-36","first-page":"121","volume-title":"Preliminary report of a prospective study in the treatment of severe acute pancreatitis","author":"Paran","year":"1995","journal-title":"J Am Coll Surg"},{"key":"key-10.4103\/1319-3767.93807-37","first-page":"20","volume-title":"Octreotide in the treatment of acute pancreatitis: results of a unicentric prospective trial with three different octreotide dosages","author":"Binder","year":"1994","journal-title":"Digestion"},{"key":"key-10.4103\/1319-3767.93807-38","first-page":"1024","volume-title":"The effect of somatostatin analogue (SMS 201-995) on pancreatic blood flow","author":"Conway","year":"1988","journal-title":"Surgery"},{"key":"key-10.4103\/1319-3767.93807-39","first-page":"168","volume-title":"Adverse effect of therapeutic vasoconstrictors in experimental acute pancreatitis","author":"Klar","year":"1991","journal-title":"Ann Surg"},{"key":"key-10.4103\/1319-3767.93807-40","first-page":"653","volume-title":"Etiology and management of pediatric chylothorax","author":"Beghetti","year":"2000","journal-title":"J Pediatr"},{"key":"key-10.4103\/1319-3767.93807-41","first-page":"938","volume-title":"Subcutaneous octreotide for the prevention of early variceal bleeding","author":"DeLedinghen","year":"1996","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.93807-42","first-page":"1361","volume-title":"Postoperative chylothorax","author":"Cerfolio","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key-10.4103\/1319-3767.93807-43","first-page":"1145","volume-title":"Aetiology and treatment of chylous ascites","author":"Browse","year":"1992","journal-title":"Br J Surg"},{"key":"key-10.4103\/1319-3767.93807-44","first-page":"149","volume-title":"The effectiveness of octreotide in the treatment of post-operative chylothorax","author":"Rosti","year":"2002","journal-title":"Eur J Pediatr"},{"key":"key-10.4103\/1319-3767.93807-45","first-page":"157","volume-title":"Octreotide for treatment of post-operative chylothorax","author":"Cheung","year":"2001","journal-title":"J Pediatr"},{"key":"key-10.4103\/1319-3767.93807-46","first-page":"E19","volume-title":"Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia","author":"Goyal","year":"2003","journal-title":"J Pediatr Surg"},{"key":"key-10.4103\/1319-3767.93807-47","first-page":"1106","volume-title":"Successful use of somatostatin in a case of neonatal chylothorax","author":"Au","year":"2003","journal-title":"J Pediatr Surg"},{"key":"key-10.4103\/1319-3767.93807-48","first-page":"440","volume-title":"Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs","author":"Nakabayashi","year":"1981","journal-title":"Diabetes"},{"key":"key-10.4103\/1319-3767.93807-49","first-page":"234","volume-title":"Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum","author":"Bhatia","year":"2001","journal-title":"Arch Dis Child"},{"key":"key-10.4103\/1319-3767.93807-50","first-page":"699","volume-title":"Octreotide in the treatment of intestinal lymphangiectasia","author":"Ballinger","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key-10.4103\/1319-3767.93807-51","first-page":"466","volume-title":"Use of a long-acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child","author":"Ohlbaum","year":"1987","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key-10.4103\/1319-3767.93807-52","first-page":"871","volume-title":"Use of a long acting somatostatin analogue in controlling ileostomy diarrhoea in infants","author":"Lamireau","year":"1990","journal-title":"Acta Pediatr Scand"},{"key":"key-10.4103\/1319-3767.93807-53","first-page":"402","volume-title":"Treatment of duodenocutaneous fistula with somatostatin analogue in a child with dermatomyositis","author":"Inamdar","year":"1990","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key-10.4103\/1319-3767.93807-54","first-page":"1020","volume-title":"Clinical response to the long acting somatostatin analogue SMS 201-995 in a child with congenital microvillus atrophy","author":"Couper","year":"1989","journal-title":"Gut"},{"key":"key-10.4103\/1319-3767.93807-55","first-page":"189","volume-title":"Successful treatment of idiopathic secretory diarrhea of infancy with the somatostatin analogue SMS 201-995","author":"Jaros","year":"1988","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.93807-56","first-page":"26","volume-title":"Tumeur carcinoide bronchique associee a une secretion exageree de prolactine (PRL) et d\u2032hormone de croissance (STH); traitement par la sandostatine et la bromocriptine","author":"Helfer","year":"1990","journal-title":"Schweiz Med Wochenschr"},{"key":"key-10.4103\/1319-3767.93807-57","first-page":"436","volume-title":"In vivo and in vitro efficacy of octreotide for treatment of enteric cryptosporidiosis","author":"Guarino","year":"1998","journal-title":"Dig Dis Sci"},{"key":"key-10.4103\/1319-3767.93807-58","first-page":"710","volume-title":"Watery diarrhea, hypokalemia, achlorohydria syndrome in an infant: effect of the long-acting somatostatin analogue SMS 201-995 on the disease and linear growth","author":"Smith","year":"1987","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key-10.4103\/1319-3767.93807-59","first-page":"678","volume-title":"Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome","author":"Geer","year":"1990","journal-title":"Ann Surg"},{"key":"key-10.4103\/1319-3767.93807-60","first-page":"155","volume-title":"Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995","author":"Hopman","year":"1988","journal-title":"Ann Surg"},{"key":"key-10.4103\/1319-3767.93807-61","first-page":"140","volume-title":"Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy","author":"Primrose","year":"1989","journal-title":"Br J Surg"},{"key":"key-10.4103\/1319-3767.93807-62","first-page":"1294","volume-title":"Long acting somatostatin analogue in dumping syndrome","author":"Tulassay","year":"1989","journal-title":"Br J Surg"},{"key":"key-10.4103\/1319-3767.93807-63","unstructured":"Petersen JM, Saltzman M, Sherwin RS, Lange R, McCallum RW. Somatostatin inhibits gastric emptying of solids and liquids in man (Abstract) Dig Dis Sci 1984;29:A64."},{"key":"key-10.4103\/1319-3767.93807-64","first-page":"1359","volume-title":"Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome","author":"Hasler","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/1319-3767.93807-65","first-page":"626","volume-title":"Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients.Clin Endocrinol (Oxf)","author":"Fatti","year":"2006","journal-title":""},{"key":"key-10.4103\/1319-3767.93807-66","first-page":"413","volume-title":"Octreotide-induced bradycardia","author":"Herrington","year":"1998","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/1319-3767.93807-67","first-page":"658","volume-title":"Octreotide: A review of its pharmacokinetic properties and therapeutic potential in conditions associated with excessive peptide secretion","author":"Battershill","year":"1989","journal-title":"Drugs"},{"key":"key-10.4103\/1319-3767.93807-68","first-page":"747","volume-title":"Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy","author":"DeClue","year":"1990","journal-title":"J Pediatr"},{"key":"key-10.4103\/1319-3767.93807-69","first-page":"71","volume-title":"Persistent hyperinsulinaemic hypoglycaemia of infancy: long-term treatment with the somatostatin analogue Sandostatin","author":"Glaser","year":"1989","journal-title":"Clin Endocrinol"},{"key":"key-10.4103\/1319-3767.93807-70","first-page":"22","volume-title":"Gallstones during octreotide therapy","author":"Dowling","year":"1992","journal-title":"Metabolism"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:59:53Z","timestamp":1786633193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-3767.93807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"alternative-id":["93807"],"URL":"https:\/\/doi.org\/10.4103\/1319-3767.93807","relation":{},"ISSN":["1319-3767"],"issn-type":[{"value":"1319-3767","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}